Intuitive Surgical reported a robust third-quarter 2025 adjusted earnings per share of $2.40, exceeding analyst expectations by 20.6%, as revenues climbed to $2.51 billion, a 22.9% increase year-on-year. The company maintains its dominance in robotic-assisted minimally invasive surgery, with 85% of revenues generated from its da Vinci systems and associated recurring services. With cash reserves of $8.4 billion and over 10,800 installed systems worldwide, Intuitive Surgical is poised to leverage an addressable market estimated to be three times its current footprint.
“Intuitive Surgical · is the undisputed leader in robotic-assisted minimally invasive surgery · true · true”
“Intuitive Surgical · posted third-quarter 2025 adjusted earnings per share · of $2.40 · beating the Zacks Consensus Estimate by 20.6%”
“Intuitive Surgical · is among · stocks to watch · true”
“Intuitive Surgical · is the top global player in · robotic surgery”
“Intuitive Surgical · dominates the multi-billion dollar market with · da Vinci systems”
“Intuitive Surgical · accounts for about · 85% of overall revenue”
“Intuitive Surgical · has cash reserves of · $8.4 billion · at the end of Q3 2025”
“Intuitive Surgical · installed · 240 da Vinci systems · in Q3 alone”
“Intuitive Surgical · is among · stocks to watch · true”
“Intuitive Surgical · is · first-to-market leader · surgical robotics”
“Intuitive Surgical · is the leading player in · robotic-assisted surgery”
“Intuitive Surgical · estimates · its current addressable market for approved procedures · around three times its current footprint”